Singapore markets closed
Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,274.05 -131.61 (-0.34%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,149.65 +5.52 (+0.07%) Bitcoin USD
57,325.04 -4,408.68 (-7.14%) CMC Crypto 200
1,225.91 -113.15 (-8.45%)
Abeona Therapeutics Inc. (ABEO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 113.52M |
| Enterprise value | 66.70M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 25.35 |
| Price/book (mrq) | 7.66 |
| Enterprise value/revenue | 19.06 |
| Enterprise value/EBITDA | -1.32 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.48 |
| 52-week change 3 | 33.55% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 9.0100 |
| 52-week low 3 | 2.8300 |
| 50-day moving average 3 | 7.0972 |
| 200-day moving average 3 | 5.0388 |
Share statistics
| Avg vol (3-month) 3 | 572.83k |
| Avg vol (10-day) 3 | 1.68M |
| Shares outstanding 5 | 27.36M |
| Implied shares outstanding 6 | 27.36M |
| Float 8 | 19.04M |
| % held by insiders 1 | 5.05% |
| % held by institutions 1 | 60.31% |
| Shares short (15 Apr 2024) 4 | 2.06M |
| Short ratio (15 Apr 2024) 4 | 6.82 |
| Short % of float (15 Apr 2024) 4 | 7.93% |
| Short % of shares outstanding (15 Apr 2024) 4 | 7.54% |
| Shares short (prior month 15 Mar 2024) 4 | 1.7M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:25 |
| Last split date 3 | 05 Jul 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,377.14% |
Management effectiveness
| Return on assets (ttm) | -46.99% |
| Return on equity (ttm) | -260.60% |
Income statement
| Revenue (ttm) | 3.5M |
| Revenue per share (ttm) | 0.16 |
| Quarterly revenue growth (yoy) | -100.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -45.91M |
| Net income avi to common (ttm) | -54.19M |
| Diluted EPS (ttm) | -2.5300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 52.23M |
| Total cash per share (mrq) | 1.91 |
| Total debt (mrq) | 5.4M |
| Total debt/equity (mrq) | 36.42% |
| Current ratio (mrq) | 4.15 |
| Book value per share (mrq) | 0.56 |
Cash flow statement
| Operating cash flow (ttm) | -37.01M |
| Levered free cash flow (ttm) | -18.89M |
© 2024 Yahoo. All rights reserved.